Sarthak Metals Limited , a player in the metal sector, has announced its financial results for the quarter ended September 30, 2025, along with significant strategic proposals that could reshape the company's future direction.

Financial Performance

For the quarter ended September 30, 2025, Sarthak Metals reported:

Strategic Initiatives

Proposed Business Diversification

In a notable move, the company's Board of Directors has proposed to amend its main object clause to include biotechnology business activities. This expansion would encompass:

• Research and development
• Manufacturing
• Trading of biotechnological products
• Enzymes
• Bio-based chemicals
• Pharmaceuticals and related products

The Board views this diversification as a strategic step towards aligning with global shifts towards sustainable and biology-driven industrial systems. The company believes that biotechnology may address dual challenges faced by industries today: reducing environmental footprint while maintaining profitability.

Board Reappointment

The Board has proposed the re-appointment of Mr. Sunil Dutt Bhatt as an Independent Director for a second five-year term, from August 2026 to August 2031. Mr. Bhatt, who has been on the company's board since August 2021, brings experience from his tenure at Bhilai Steel Plant, Steel Authority of India Limited.

Shareholder Approval Process

Both the biotechnology diversification and the director re-appointment proposals will be subject to shareholder approval through a postal ballot. The e-voting period for these resolutions is scheduled from November 13 to December 12, 2025.

Market Implications

These developments signal Sarthak Metals' intent to diversify beyond its traditional metal sector focus. The proposed entry into biotechnology, if approved, could open new revenue streams and position the company in a different sector.

Investors and market watchers will likely be keen to observe how this diversification strategy unfolds and its potential impact on the company's future growth trajectory and financial performance.

As Sarthak Metals considers this potential transformation, stakeholders will be watching closely to see how the company plans to balance its established metal business with the new biotechnology ventures, should the proposal receive shareholder approval.

Sarthak Metals Limited (SML) has announced the resignation of its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), Anirudh Singhal. The company disclosed this information in a regulatory filing to the BSE and NSE on August 16, 2025.

Resignation Details

Anirudh Singhal will be relieved from his duties at the close of business hours on July 31, 2025. The company stated that there were no material reasons provided for his resignation.

Disclosure Process

Sarthak Metals explained that the initial disclosure delay was due to receiving only an email notification without an attached formal resignation letter. The company has since provided a PDF copy of the email as part of their regulatory filing.

Company's Statement

In its filing, Sarthak Metals expressed appreciation for Singhal's services, stating, "The Company places on record its deep sense of appreciation for the services rendered by Mr. Anirudh Singhal and for his contribution during his tenure as the CFO."

CFO's Parting Words

In his resignation email, Singhal wrote, "I am grateful for the exposure provided by SML and happy to be part of SML's incredible journey. Best of luck to the team in all future endeavors."

Regulatory Compliance

The company's disclosure adheres to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the recent SEBI circular dated November 11, 2024.

Sarthak Metals Limited will now be in the process of finding a suitable replacement for the CFO position. The company has not yet announced any plans for Singhal's successor.